Picard Medical (PMI) Common Equity (2024 - 2026)

Picard Medical's Common Equity history runs 3 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• Quarterly Common Equity rose 97.04% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 97.04% YoY) and the FY2025 annual result came in at $3.8 million, up 108.61% from the prior year.
• Common Equity was -$1.4 million for Q1 2026 at Picard Medical, down from $3.8 million in the prior quarter.
• Across five years, Common Equity topped out at $8.0 million in Q3 2025 and bottomed at -$54.5 million in Q2 2025.
• A 3-year average of -$25.3 million and a median of -$32.5 million in 2024 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 122.51% in 2025, while the deepest fall reached 83.88% in 2025.
• Picard Medical's Common Equity stood at -$44.0 million in 2024, then soared by 108.61% to $3.8 million in 2025, then slumped by 138.22% to -$1.4 million in 2026.
• Business Quant data shows PMI's Common Equity at -$1.4 million in Q1 2026, $3.8 million in Q4 2025, and $8.0 million in Q3 2025.